{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:26:46Z","timestamp":1784903206252,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Defining the tumor immune microenvironment (TIME) of patients using transcriptome analysis is gaining more popularity. Here, we examined and discussed the pros and cons of using RNA sequencing for fresh frozen samples and targeted gene expression immune profiles (NanoString) for formalin-fixed, paraffin-embedded (FFPE) samples to characterize the TIME of ependymoma samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results showed a stable expression of the 40 housekeeping genes throughout all samples. The Pearson correlation of the endogenous genes was high. To define the TIME, we first checked the expression of the <jats:italic>PTPRC<\/jats:italic> gene, known as <jats:italic>CD45<\/jats:italic>, and found it was above the detection limit in all samples by both techniques. T cells were identified consistently using the two types of data. In addition, both techniques showed that the immune landscape was heterogeneous in the 6 ependymoma samples used for this study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The low-abundant genes were detected in higher quantities using the NanoString technique, even when FFPE samples were used. RNA sequencing is better suited for biomarker discovery, fusion gene detection, and getting a broader overview of the TIME. The technique that was used to measure the samples had a considerable effect on the type of immune cells that were identified. The limited number of tumor-infiltrating immune cells compared to the high density of tumor cells in ependymoma can limit the sensitivity of RNA expression techniques regarding the identification of the infiltrating immune cells.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00262-023-03450-2","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:03:16Z","timestamp":1681876996000},"page":"2659-2670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencing"],"prefix":"10.1007","volume":"72","author":[{"given":"W.","family":"de Koning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. F.","family":"Feenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G. J.","family":"Calkoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van der Lugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A. M.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"3450_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K et al (2021) Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39:845-865.e7. https:\/\/doi.org\/10.1016\/j.ccell.2021.04.014","journal-title":"Cancer Cell"},{"key":"3450_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41576-019-0150-2","volume":"20","author":"R Stark","year":"2019","unstructured":"Stark R, Grzelak M, Hadfield J (2019) RNA sequencing: the teenage years. Nat Rev Genet 20:631\u2013656. https:\/\/doi.org\/10.1038\/s41576-019-0150-2","journal-title":"Nat Rev Genet"},{"key":"3450_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fgene.2019.00384","volume":"10","author":"B Wang","year":"2019","unstructured":"Wang B, Kumar V, Olson A, Ware D (2019) Reviving the transcriptome studies: an insight into the emergence of single-molecule transcriptome sequencing. Front Genet 10:384. https:\/\/doi.org\/10.3389\/fgene.2019.00384","journal-title":"Front Genet"},{"key":"3450_CR4","unstructured":"Bourr\u00e9 L (2020) Genome-wide RNAseq and array-based NanoString transcriptomic technologies: which to use and when? https:\/\/blog.crownbio.com\/genome-wide-rnaseq-and-array-based-nanostring-transcriptomic-technologies. Accessed 21 Jul 2021"},{"key":"3450_CR5","doi-asserted-by":"publisher","first-page":"14756","DOI":"10.1038\/s41598-017-15145-7","volume":"7","author":"E Speranza","year":"2017","unstructured":"Speranza E, Altamura LA, Kulcsar K et al (2017) Comparison of transcriptomic platforms for analysis of whole blood from Ebola-infected cynomolgus macaques. Sci Rep 7:14756. https:\/\/doi.org\/10.1038\/s41598-017-15145-7","journal-title":"Sci Rep"},{"key":"3450_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15145-7","volume":"7","author":"E Speranza","year":"2017","unstructured":"Speranza E, Altamura LA, Kulcsar K et al (2017) Comparison of transcriptomic platforms for analysis of whole blood from Ebola-infected cynomolgus macaques. Sci Rep 7:1\u201315. https:\/\/doi.org\/10.1038\/s41598-017-15145-7","journal-title":"Sci Rep"},{"key":"3450_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-4939-3801-8_21","volume":"1458","author":"M-N M\u2019Boutchou","year":"2016","unstructured":"M\u2019Boutchou M-N, van Kempen LC (2016) Analysis of the tumor microenvironment transcriptome via NanoString mRNA and miRNA expression profiling. Methods Mol Biol 1458:291\u2013310. https:\/\/doi.org\/10.1007\/978-1-4939-3801-8_21","journal-title":"Methods Mol Biol"},{"key":"3450_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-016-0225-2","volume":"9","author":"B Omolo","year":"2016","unstructured":"Omolo B, Yang M, Lo FY et al (2016) Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer. BMC Med Genomics 9:1\u201310. https:\/\/doi.org\/10.1186\/s12920-016-0225-2","journal-title":"BMC Med Genomics"},{"key":"3450_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12920-016-0225-2","volume":"9","author":"B Omolo","year":"2016","unstructured":"Omolo B, Yang M, Lo FY et al (2016) Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer. BMC Med Genomics 9:65. https:\/\/doi.org\/10.1186\/s12920-016-0225-2","journal-title":"BMC Med Genomics"},{"key":"3450_CR10","unstructured":"NanoString (2021) nCounter\u00ae PanCancer immune profiling panel. https:\/\/www.nanostring.com\/products\/ncounter-assays-panels\/oncology\/pancancer-immune-profiling\/. Accessed 21 Jul 2021"},{"key":"3450_CR11","unstructured":"NanoString (2021) SolverTM data analysis support. https:\/\/www.nanostring.com\/products\/analysis-solutions\/ncounter-analysis-solutions\/nsolver-data-analysis-support\/. Accessed 21 Jul 2021"},{"key":"3450_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00401-013-1212-8","volume":"127","author":"LM Hoffman","year":"2014","unstructured":"Hoffman LM, Donson AM, Nakachi I et al (2014) Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma. Acta Neuropathol 127:731\u2013745. https:\/\/doi.org\/10.1007\/s00401-013-1212-8","journal-title":"Acta Neuropathol"},{"key":"3450_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.26960","volume":"65","author":"DA Witt","year":"2018","unstructured":"Witt DA, Donson AM, Amani V et al (2018) Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: implications for PD-1-targeted therapy. Pediatr Blood Cancer 65:1\u20139. https:\/\/doi.org\/10.1002\/pbc.26960","journal-title":"Pediatr Blood Cancer"},{"key":"3450_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature25169","volume":"553","author":"SC Mack","year":"2018","unstructured":"Mack SC, Pajtler KW, Chavez L et al (2018) Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature 553:101\u2013105. https:\/\/doi.org\/10.1038\/nature25169","journal-title":"Nature"},{"key":"3450_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.critrevonc.2007.03.004","volume":"63","author":"M Reni","year":"2007","unstructured":"Reni M, Gatta G, Mazza E, Vecht C (2007) Ependymoma. Crit Rev Oncol Hematol 63:81\u201389. https:\/\/doi.org\/10.1016\/j.critrevonc.2007.03.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"3450_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728\u2013743. https:\/\/doi.org\/10.1016\/j.ccell.2015.04.002","journal-title":"Cancer Cell"},{"key":"3450_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41586-019-1158-7","volume":"572","author":"MC Vladoiu","year":"2019","unstructured":"Vladoiu MC, El-Hamamy I, Donovan LK et al (2019) Childhood cerebellar tumours mirror conserved fetal transcriptional programs. Nature 572:67\u201373. https:\/\/doi.org\/10.1038\/s41586-019-1158-7","journal-title":"Nature"},{"key":"3450_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/brainsci7100137","volume":"7","author":"EJ Sayour","year":"2017","unstructured":"Sayour EJ, Mitchell DA (2017) Immunotherapy for pediatric brain tumors. Brain Sci 7:137. https:\/\/doi.org\/10.3390\/brainsci7100137","journal-title":"Brain Sci"},{"key":"3450_CR19","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.4049\/jimmunol.1301966","volume":"191","author":"AM Griesinger","year":"2013","unstructured":"Griesinger AM, Birks DK, Donson AM et al (2013) Characterization of distinct immunophenotypes across pediatric brain tumor types. J Immunol 191:4880\u20134888. https:\/\/doi.org\/10.4049\/jimmunol.1301966","journal-title":"J Immunol"},{"key":"3450_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00262-018-2278-x","volume":"68","author":"SJ Nam","year":"2019","unstructured":"Nam SJ, Kim Y-H, Park JE et al (2019) Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma. Cancer Immunol Immunother 68:305\u2013318. https:\/\/doi.org\/10.1007\/s00262-018-2278-x","journal-title":"Cancer Immunol Immunother"},{"key":"3450_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.it.2019.05.009","volume":"40","author":"SS Wang","year":"2019","unstructured":"Wang SS, Bandopadhayay P, Jenkins MR (2019) Towards immunotherapy for pediatric brain tumors. Trends Immunol 40:748\u2013761. https:\/\/doi.org\/10.1016\/j.it.2019.05.009","journal-title":"Trends Immunol"},{"key":"3450_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1398877","author":"JF Vermeulen","year":"2018","unstructured":"Vermeulen JF, Van Hecke W, Adriaansen EJM et al (2018) Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma. Oncoimmunology. https:\/\/doi.org\/10.1080\/2162402X.2017.1398877","journal-title":"Oncoimmunology"},{"key":"3450_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","volume":"6","author":"Q Duan","year":"2020","unstructured":"Duan Q, Zhang H, Zheng J, Zhang L (2020) Turning cold into hot: firing up the tumor microenvironment. Trends Cancer 6:605\u2013618. https:\/\/doi.org\/10.1016\/j.trecan.2020.02.022","journal-title":"Trends Cancer"},{"key":"3450_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12864-020-6643-8\/FIGURES\/10","volume":"21","author":"W Zhang","year":"2020","unstructured":"Zhang W, Petegrosso R, Chang JW et al (2020) A large-scale comparative study of isoform expressions measured on four platforms. BMC Genomics 21:1\u201314. https:\/\/doi.org\/10.1186\/S12864-020-6643-8\/FIGURES\/10","journal-title":"BMC Genomics"},{"key":"3450_CR25","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.14440\/JBM.2020.300","volume":"7","author":"G Bondar","year":"2020","unstructured":"Bondar G, Xu W, Elashoff D et al (2020) Comparing NGS and NanoString platforms in peripheral blood mononuclear cell transcriptome profiling for advanced heart failure biomarker development. J Biol Methods 7:e123. https:\/\/doi.org\/10.14440\/JBM.2020.300","journal-title":"J Biol Methods"},{"key":"3450_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/BIOINFORMATICS\/BTS635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTS635","journal-title":"Bioinformatics"},{"key":"3450_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/BIOINFORMATICS\/BTT656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923\u2013930. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTT656","journal-title":"Bioinformatics"},{"key":"3450_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12859-018-2246-7\/TABLES\/2","volume":"19","author":"M Smid","year":"2018","unstructured":"Smid M, Coebergh van den Braak RRJ, van de Werken HJG et al (2018) Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons. BMC Bioinform 19:1\u201313. https:\/\/doi.org\/10.1186\/S12859-018-2246-7\/TABLES\/2","journal-title":"BMC Bioinform"},{"key":"3450_CR29","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, de Preter K, Pattyn F et al (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034. https:\/\/doi.org\/10.1186\/gb-2002-3-7-research0034","journal-title":"Genome Biol"},{"key":"3450_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649061","author":"W de Koning","year":"2021","unstructured":"de Koning W, Latifi D, Li Y et al (2021) Identification, validation, and utilization of immune cells in pancreatic ductal adenocarcinoma based on marker genes. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.649061","journal-title":"Front Immunol"},{"key":"3450_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat Methods"},{"key":"3450_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17:218. https:\/\/doi.org\/10.1186\/s13059-016-1070-5","journal-title":"Genome Biol"},{"key":"3450_CR33","unstructured":"R Core Team (2020) R: a language and environment for statistical computing"},{"key":"3450_CR34","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-15-0262","volume":"75","author":"MH Veldman-Jones","year":"2015","unstructured":"Veldman-Jones MH, Brant R, Rooney C et al (2015) Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Res 75:2587\u20132593. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0262","journal-title":"Cancer Res"},{"key":"3450_CR35","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/BIOINFORMATICS\/BTR005","volume":"27","author":"L Gao","year":"2011","unstructured":"Gao L, Fang Z, Zhang K et al (2011) Length bias correction for RNA-seq data in gene set analyses. Bioinformatics 27:662. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTR005","journal-title":"Bioinformatics"},{"key":"3450_CR36","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/nn.4610","volume":"20","author":"B Korin","year":"2017","unstructured":"Korin B, Ben-Shaanan TL, Schiller M et al (2017) High-dimensional, single-cell characterization of the brain\u2019s immune compartment. Nat Neurosci 20:1300\u20131309. https:\/\/doi.org\/10.1038\/nn.4610","journal-title":"Nat Neurosci"},{"key":"3450_CR37","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.4049\/JIMMUNOL.0902811","volume":"183","author":"AM Donson","year":"2009","unstructured":"Donson AM, Birks DK, Barton VN et al (2009) Immune gene and cell enrichment is associated with a good prognosis in ependymoma. J Immunol 183:7428\u20137440. https:\/\/doi.org\/10.4049\/JIMMUNOL.0902811","journal-title":"J Immunol"},{"key":"3450_CR38","doi-asserted-by":"publisher","first-page":"108023","DOI":"10.1016\/J.CELREP.2020.108023","volume":"32","author":"AE Gillen","year":"2020","unstructured":"Gillen AE, Riemondy KA, Amani V et al (2020) Single-cell RNA sequencing of childhood ependymoma reveals neoplastic cell subpopulations that impact molecular classification and etiology. Cell Rep 32:108023. https:\/\/doi.org\/10.1016\/J.CELREP.2020.108023","journal-title":"Cell Rep"},{"key":"3450_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864423","author":"JS Rozowsky","year":"2022","unstructured":"Rozowsky JS, Meesters-Ensing JI, Lammers JAS et al (2022) A toolkit for profiling the immune landscape of pediatric central nervous system malignancies. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.864423","journal-title":"Front Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-023-03450-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:21:48Z","timestamp":1689996108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-023-03450-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3450"],"URL":"https:\/\/doi.org\/10.1007\/s00262-023-03450-2","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The BioBank committee of the Princess Maxima Center approved our application (PMCLAB2020.164). Informed written consent was obtained from each subject. In addition, this study is in line with the declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}